Search research articles
Contact Us
Filters
Showing results (311-320 of 329) with videos related to
Page
of 33
Sort By:
The Lancet. Neurology
|
February 10, 2015
Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis
Jonathan D Rohrer, Jennifer M Nicholas, David M Cash, et al.
Frontiers in Neurology
|
January 7, 2021
New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab
Inmaculada Toboso, Amalia Tejeda-Velarde, Roberto Alvarez-Lafuente, et al.
Journal of Alzheimer'S Disease : JAD
|
September 18, 2010
The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study
Jean-Charles Lambert, Kristel Sleegers, Antonio González-Pérez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 26, 2011
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers
Niklas Mattsson, Ulf Andreasson, Staffan Persson, et al.
Brain : a Journal of Neurology
|
September 26, 2018
A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers
Ming Zhang, Raffaele Ferrari, Maria Carmela Tartaglia, et al.
Cell Genomics
|
October 22, 2024
Mechanism-free repurposing of drugs for C9orf72-related ALS/FTD using large-scale genomic data
Sara Saez-Atienzar, Cleide Dos Santos Souza, Ruth Chia, et al.
The Lancet. Neurology
|
December 8, 2019
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study
Katrina M Moore, Jennifer Nicholas, Murray Grossman, et al.
Neurology
|
September 18, 2020
<i>C9orf72</i>, age at onset, and ancestry help discriminate behavioral from language variants in FTLD cohorts
Beatrice Costa, Claudia Manzoni, Manuel Bernal-Quiros, et al.
The Lancet. Neurology
|
May 5, 2018
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study
Cyril Pottier, Xiaolai Zhou, Ralph B Perkerson, et al.
Nature Genetics
|
April 5, 2011
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
Paul Hollingworth, Denise Harold, Rebecca Sims, et al.
Page
of 33
Search research articles
Search
Showing results (311-320 of 329) with videos related to
Sort By:
Page
of 33
The Lancet. Neurology
|
February 10, 2015
Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis
Jonathan D Rohrer, Jennifer M Nicholas, David M Cash, et al.
Frontiers in Neurology
|
January 7, 2021
New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab
Inmaculada Toboso, Amalia Tejeda-Velarde, Roberto Alvarez-Lafuente, et al.
Journal of Alzheimer'S Disease : JAD
|
September 18, 2010
The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study
Jean-Charles Lambert, Kristel Sleegers, Antonio González-Pérez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 26, 2011
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers
Niklas Mattsson, Ulf Andreasson, Staffan Persson, et al.
Brain : a Journal of Neurology
|
September 26, 2018
A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers
Ming Zhang, Raffaele Ferrari, Maria Carmela Tartaglia, et al.
Cell Genomics
|
October 22, 2024
Mechanism-free repurposing of drugs for C9orf72-related ALS/FTD using large-scale genomic data
Sara Saez-Atienzar, Cleide Dos Santos Souza, Ruth Chia, et al.
The Lancet. Neurology
|
December 8, 2019
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study
Katrina M Moore, Jennifer Nicholas, Murray Grossman, et al.
Neurology
|
September 18, 2020
<i>C9orf72</i>, age at onset, and ancestry help discriminate behavioral from language variants in FTLD cohorts
Beatrice Costa, Claudia Manzoni, Manuel Bernal-Quiros, et al.
The Lancet. Neurology
|
May 5, 2018
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study
Cyril Pottier, Xiaolai Zhou, Ralph B Perkerson, et al.
Nature Genetics
|
April 5, 2011
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
Paul Hollingworth, Denise Harold, Rebecca Sims, et al.
Page
of 33